Position in LCTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$33,432
-$91,660 QoQ
Shares Held
21,160
-74.6% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
7 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in LCTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026LMR Partners LLP holds $224,816,570 across 60 Biotechnology names. LCTX ranks #53 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
74,661 | $24,703,084 | |
| 2 | ACLX |
Arcellx, Inc.
|
212,495 | $24,398,675 | |
| 3 | TERN |
Terns Pharmaceuticals, Inc.
|
400,000 | $21,088,000 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
324,939 | $18,355,804 | |
| 5 | ARGX |
Argenx SE
|
23,488 | $17,152,112 | |
| 6 | APLS |
Apellis Pharmaceuticals, Inc.
|
403,622 | $16,237,713 | |
| 7 | FOLD |
AMICUS THERAPEUTICS, INC.
|
1,049,700 | $15,178,662 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
130,000 | $12,642,500 |
All Filings in LCTX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $33,432 | 21,160 | Shares | Other | 2026-05-15 | |
| 2023-03-31 | $125,092 | 83,395 | Shares | Sole | 2023-05-15 | |
| 2022-09-30 | $50,548 | 44,733 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $70,678 | 44,733 | Shares | Sole | 2022-08-15 | |
| 2021-03-31 | $169,655 | 72,194 | Shares | Sole | 2021-05-17 | |
| 2020-09-30 | $37,678 | 40,083 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $41,026 | 47,157 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||